Parlaying its biotech brand, J.P. Morgan building venture business

One year into its new venture investment strategy led by industry veterans, J.P. Morgan is starting to leverage its historic presence in the biotech sector on the private side.

J.P. Morgan has been synonymous with the biotech sector for decades. But that brand has almost exclusively been focused on the public markets. According to Chief Investment Officer Stephen Squinto, the decision came from the top to make a bigger push into sectors such as tech and biotech, where the bank has long been a leader...